Sponsor intelligence · OTHER

Clinical trials sponsored by
Sun Yat-Sen University.

Real, source-linked trial activity for Sun Yat-Sen University: 13 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.

✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.

PHASE2 8NA 3PHASE3 2

Newest Sun Yat-Sen University trials

PostedTrialPhaseStatus
2d ago Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation i NA NOT_YET_RECRUITING
19d ago Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chem Ph 3 RECRUITING
23d ago Effects of Different PICC Catheterization Methods: A Multicenter Rando NA NOT_YET_RECRUITING
31d ago Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigato Ph 2 NOT_YET_RECRUITING
31d ago Research on Colorectal Cancer Recurrence Monitoring and Individualized NA RECRUITING
32d ago Radiotherapy Combined With Capeox Chemotherapy, Sintilimab and Suvemci Ph 2 NOT_YET_RECRUITING
34d ago Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab ( Ph 2 NOT_YET_RECRUITING
41d ago Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Ph 2 NOT_YET_RECRUITING
44d ago Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-f Ph 2 NOT_YET_RECRUITING
47d ago Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2 Ph 2 NOT_YET_RECRUITING
55d ago Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome Ph 2 NOT_YET_RECRUITING
55d ago FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC Ph 3 NOT_YET_RECRUITING
62d ago Efficacy and Safety of Tunlametinib Combination Therapy in the Treatme Ph 2 NOT_YET_RECRUITING

Get this lane pushed to you the day a new grant or trial lands

Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Sun Yat-Sen University (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.